Sfoglia per Autore
Ocular complications of diabetes mellitus in a pediatric population and proposals for screening and follow-up programs
2023-01-01 Diplotti, Laura; Pignatto, Silvia; Franco, Francesca; Zanatta, Manuela; Veritti, Daniele; Cogo, Paola; Lanzetta, Paolo
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose
2023-01-01 Veritti, Daniele; Sarao, Valentina; Di Bin, Francesco; Lanzetta, Paolo
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination
2023-01-01 Lin, T. P. H.; Sen, M.; Gupta, V.; Agrawal, R.; Lanzetta, P.; Giannaccare, G.; Chan, C. K. M.; Agrawal, K.; Menia, N. K.; Rojas-Carabali, W.; Arora, A.; Martinuzzi, D.; Taloni, A.; Rubinato, L.; Coco, G.; Sarao, V.; Veritti, D.; Chen, L.; Honavar, S. G.; Lam, D. S. C.
The Present and Future of Optic Pathway Glioma Therapy
2023-01-01 Dal Bello, S.; Martinuzzi, D.; Tereshko, Y.; Veritti, D.; Sarao, V.; Gigli, G. L.; Lanzetta, P.; Valente, M.
Stem cell therapy in retinal diseases: current evidence
2023-01-01 Rubinato, L.; Redolfi de Zan, E.; Sarao, V.; Veritti, D.; Lanzetta, P.
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey
2023-01-01 Veritti, Daniele; Sarao, Valentina; Chhablani, Jay; Loewenstein, Anat; Lanzetta, Paolo; Società Italiana della Retina (SIR) Study, Group
Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs
2024-01-01 Veritti, D.; Sarao, V.; Martinuzzi, D.; Menzio, S.; Lanzetta, P.
Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data
2024-01-01 Boscia, F.; Veritti, D.; Iaculli, C.; Lattanzio, R.; Freda, S.; Piergentili, B.; Varano, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Ocular complications of diabetes mellitus in a pediatric population and proposals for screening and follow-up programs | 1-gen-2023 | Diplotti, Laura; Pignatto, Silvia; Franco, Francesca; Zanatta, Manuela; Veritti, Daniele; Cogo, Paola; Lanzetta, Paolo | |
| Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose | 1-gen-2023 | Veritti, Daniele; Sarao, Valentina; Di Bin, Francesco; Lanzetta, Paolo | |
| Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination | 1-gen-2023 | Lin, T. P. H.; Sen, M.; Gupta, V.; Agrawal, R.; Lanzetta, P.; Giannaccare, G.; Chan, C. K. M.; Agrawal, K.; Menia, N. K.; Rojas-Carabali, W.; Arora, A.; Martinuzzi, D.; Taloni, A.; Rubinato, L.; Coco, G.; Sarao, V.; Veritti, D.; Chen, L.; Honavar, S. G.; Lam, D. S. C. | |
| The Present and Future of Optic Pathway Glioma Therapy | 1-gen-2023 | Dal Bello, S.; Martinuzzi, D.; Tereshko, Y.; Veritti, D.; Sarao, V.; Gigli, G. L.; Lanzetta, P.; Valente, M. | |
| Stem cell therapy in retinal diseases: current evidence | 1-gen-2023 | Rubinato, L.; Redolfi de Zan, E.; Sarao, V.; Veritti, D.; Lanzetta, P. | |
| The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey | 1-gen-2023 | Veritti, Daniele; Sarao, Valentina; Chhablani, Jay; Loewenstein, Anat; Lanzetta, Paolo; Società Italiana della Retina (SIR) Study, Group | |
| Submacular Hemorrhage during Neovascular Age-Related Macular Degeneration: A Meta-Analysis and Meta-Regression on the Use of tPA and Anti-VEGFs | 1-gen-2024 | Veritti, D.; Sarao, V.; Martinuzzi, D.; Menzio, S.; Lanzetta, P. | |
| Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data | 1-gen-2024 | Boscia, F.; Veritti, D.; Iaculli, C.; Lattanzio, R.; Freda, S.; Piergentili, B.; Varano, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile